| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 19, 2026 | Sell(S) | 31K | $1.65 | $51K | 0 |
| Aug 19, 2026 | Option exercise(M) | 13K | $0.72 | $10K | 62K |
| Aug 19, 2026 | Option exercise(M) | 18K | $0.72 | $13K | 80K |
| Aug 19, 2026 | Sell(S) | 31K | $1.65 | $51K | 49K |
| Aug 19, 2026 | Option exercise(M) | 31K | $0.72 | $22K | 31K |
| Aug 18, 2026 | Sell(S) | 34K | $1.58 | $54K | 49K |
| Aug 18, 2026 | Option exercise(M) | 35K | $0.72 | $25K | 35K |
| Aug 18, 2026 | Sell(S) | 35K | $1.59 | $55K | 0 |
| Aug 18, 2026 | Option exercise(M) | 34K | $0.72 | $25K | 83K |
| Aug 17, 2026 | Option exercise(M) | 41K | $0.72 | $29K | 124K |
| Aug 17, 2026 | Option exercise(M) | 15K | $0.72 | $11K | 139K |
| Aug 17, 2026 | Option exercise(M) | 1K | $0.72 | $1K | 140K |
| Aug 17, 2026 | Option exercise(M) | 1 | $0.72 | $1 | 140K |
| Aug 17, 2026 | Sell(S) | 58K | $1.51 | $87K | 83K |
| Aug 17, 2026 | Sell(S) | 34K | $1.49 | $51K | 49K |
| Aug 17, 2026 | Option exercise(M) | 25K | $0.72 | $18K | 25K |
| Aug 17, 2026 | Option exercise(M) | 30K | $0.72 | $21K | 55K |
| Aug 17, 2026 | Sell(S) | 55K | $1.50 | $83K | 0 |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 19, 2026 | Option exercise(M) | 13K | — | $0 | 23K |
| Aug 19, 2026 | Option exercise(M) | 18K | — | $0 | 177K |
| Aug 19, 2026 | Option exercise(M) | 31K | — | $0 | 45K |
| Aug 18, 2026 | Option exercise(M) | 34K | — | $0 | 37K |
| Aug 18, 2026 | Option exercise(M) | 35K | — | $0 | 76K |
| Aug 17, 2026 | Option exercise(M) | 41K | — | $0 | 0 |
| Aug 17, 2026 | Option exercise(M) | 30K | — | $0 | 0 |
| Aug 17, 2026 | Option exercise(M) | 15K | — | $0 | 193K |
| Aug 17, 2026 | Option exercise(M) | 1K | — | $0 | 71K |
| Aug 17, 2026 | Option exercise(M) | 1 | — | $0 | 1000K |
| Aug 17, 2026 | Option exercise(M) | 25K | — | $0 | 111K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000362) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Neumora Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001610717-26-000362"
Use Arkolith to summarize insider buying and selling at Neumora Therapeutics, Inc. over the last 90 days and cite the filings.